SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-115943
Filing Date
2024-04-26
Accepted
2024-04-26 08:34:50
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq Description Document Type Size
1 ARS d797640dars.pdf ARS 2046868
  Complete submission text file 0001193125-24-115943.txt   2813578
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36483 | Film No.: 24879023
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)